On Wednesday, Oct. 15, more than 250 people gathered at the Harvard Club in Boston to celebrate 10 years of leading Alzheimer’s research, hear the latest progress on finding a cure, and honor Charles Collier, Alzheimer’s advocate and former senior philanthropic adviser to Harvard University. The Harvard Club was a particularly appropriate choice for our fourth annual research symposium, since some of the early discussions on what would eventually become Cure Alzheimer’s Fund happened there a decade ago.
On the day of the symposium, Jeff Morby, co-founder of Cure Alzheimer’s Fund, gave the opening remarks, and Rudy Tanzi, Ph.D., of Harvard Medical School/Massachusetts General Hospital and chairman of Cure Alzheimer’s Fund Research Consortium, gave a presentation on our approach and the state of Alzheimer’s research today.
Looking back over the past 10 years, Cure Alzheimer’s Fund has spent more than $26 million on research, funded more than 80 research projects in 31 labs in 14 states and two foreign countries, and generated almost 150 papers, which have been cited 7,700 times. In addition, our founders and board have covered more than $9 million worth of expenses and our “proof of concept” research has been extended by more than $35 million from the National Institutes of Health and other organizations. These investments have positioned us to move to more aggressive therapies and have allowed us to make research our top priority. Many thanks to our founders, funders and researchers for 10 years of dedicated service!
Watch the main presentation by Dr. Tanzi above. Below, see Chairman & Co-Founder Jeff Morby’s welcome, Charles Collier’s award and “red carpet” interviews by David Shenk.
To see the full symposium program (1 hour 40 minutes), click here.